IL-17 enhances PI3K/AKT signaling in GBM cells, upregulating BMI1 and Twist transcription factors and leading to the overexpression of matrix metalloproteinases 2/9 (MMP-2/9) and cyclin D [15]. The gene discussed is IL17A; the disease is glioblastoma.